Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Safety, Pharmacokinetics and Preliminary Efficacy of HMPL-523 in Adult Patients with Primary Immune Thrombocytopenia: A Randomized, Double-Blind and Placebo-Controlled Phase 1b Study

Blood (2021) 138 (Supplement 1): 16.

https://doi.org/10.1182/blood-2021-149895

Published: 2021

Journal Articles

Compared the Effect of Mitroxantrone ( MA) with Idarubicine (IA) for Acute Myeloid Leukemia Induction Therapy

Peilong Lai, Mingyan Wu, Minming Li, Chengxin Deng, Zesheng Lu, Chenwei Luo, Xin Huang, Pengjun Liao, Lisi Huang, Ping Wu, Wang Yulian, Changchun Wan, Wei Ling, Liye Zhong, Suijing Wu, Xin Du, MD PhD, Jianyu Weng, MD

Blood (2018) 132 (Supplement 1): 5229.

https://doi.org/10.1182/blood-2018-99-116234

Published: 2018

Journal Articles

Selective Targeting of B Cells with Mesenchymal Stromal Cells Treatment Is An Efficacious Strategy for Cutaneous Cgvhd,

Peilong Lai, Jianyu Weng, Chenwei Luo, Rong Guo, Zesheng Lu, Suxia Geng, Xin Du, PhD, Suijing Wu

Blood (2011) 118 (21): 4086.

https://doi.org/10.1182/blood.V118.21.4086.4086

Published: 2011

Journal Articles

Mesenchymal Stem Cells Relieve Chronic GVHD Via Modulation the Ratio of CD8+CD28-/CD8+CD28+T Cells.

Jianyu Weng, MD, Xin Du, PhD, Suxia Geng, MD, Maohua Zhou, MD, Yanwen Peng, Zhen Wang, Zesheng Lu, Suijing Wu, MD, Chenwei Luo, MD, Rong Guo, PhD, Wei Ling, PhD, Chengxin Deng, Pengjun Liao, Andy Peng Xiang, Ph.D

Blood (2009) 114 (22): 4501.

https://doi.org/10.1182/blood.V114.22.4501.4501

Published: 2009

Journal Articles

The Studies on the T-Cell Receptor Repertoire Diversity and Flow Cytometric Analysis in a Patient with MAS/HPS after Unrelated Peripheral Blood Stem Cell Transplantation.

Xin Du, MD, PhD, Yangqiu Li, MD, Suxia Geng, MD, Jianyu Weng, MD, Zesheng Lu, MD, Suijin Wu, MD, Chenxin Deng, MD, Wei Ling, MD, Haizhou Xing, MD, Changchun Wan, MD, Chenwei Luo, MD, Liye Zhong, MD, Miaorong She, MD, Xiaoli Zhou, MD, Qunhua Li, MD, Wei Lin, MD, Zilun Huang, MD, Shaohua Chen, MD

Blood (2007) 110 (11): 4970.

https://doi.org/10.1182/blood.V110.11.4970.4970

Published: 2007

NARROW

Safety, Pharmacokinetics and Preliminary Efficacy of HMPL-523 in Adult Patients with Primary Immune Thrombocytopenia: A Randomized, Double-Blind and Placebo-Controlled Phase 1b Study

Compared the Effect of Mitroxantrone ( MA) with Idarubicine (IA) for Acute Myeloid Leukemia Induction Therapy

Selective Targeting of B Cells with Mesenchymal Stromal Cells Treatment Is An Efficacious Strategy for Cutaneous Cgvhd,

Mesenchymal Stem Cells Relieve Chronic GVHD Via Modulation the Ratio of CD8+CD28-/CD8+CD28+T Cells.

The Studies on the T-Cell Receptor Repertoire Diversity and Flow Cytometric Analysis in a Patient with MAS/HPS after Unrelated Peripheral Blood Stem Cell Transplantation.

Email alerts

ASH Publications

American Society of Hematology

Safety, Pharmacokinetics and Preliminary Efficacy of HMPL-523 in Adult Patients with Primary Immune Thrombocytopenia: A Randomized, Double-Blind and Placebo-Controlled Phase 1b Study

Compared the Effect of Mitroxantrone ( MA) with Idarubicine (IA) for Acute Myeloid Leukemia Induction Therapy

Selective Targeting of B Cells with Mesenchymal Stromal Cells Treatment Is An Efficacious Strategy for Cutaneous Cgvhd,

Mesenchymal Stem Cells Relieve Chronic GVHD Via Modulation the Ratio of CD8+CD28-/CD8+CD28+T Cells.

The Studies on the T-Cell Receptor Repertoire Diversity and Flow Cytometric Analysis in a Patient with MAS/HPS after Unrelated Peripheral Blood Stem Cell Transplantation.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only